| 期 |
标题 |
文件 |
| 卷 31, 编号 26 (2024) |
Current Computational Methods for Protein-peptide Complex Structure Prediction |
(Eng)
|
|
Yang C., Xu X., Xiang C.
|
| 卷 31, 编号 27 (2024) |
Selective Activation of G Protein-coupled Estrogen Receptor 1 Attenuates Atherosclerosis |
(Eng)
|
|
Haider M., Sahebkar A., Eid A.
|
| 卷 31, 编号 27 (2024) |
The Application of Graphene Oxide Nanoarchitectures in the Treatment of Cancer: Phototherapy, Immunotherapy, and the Development of Vaccines |
(Eng)
|
|
Bhattacharya S., Belemkar S., Prajapati B.
|
| 卷 31, 编号 27 (2024) |
Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways |
(Eng)
|
|
Poortalebi H., ZareDini M., Foroughi-Nematollahi S., Farkhondeh T., Samarghandian S., Pourhanifeh M.
|
| 卷 31, 编号 27 (2024) |
CAR-T Therapy in Relapsed Refractory Multiple Myeloma |
(Eng)
|
|
Ding H., Wu Y.
|
| 卷 31, 编号 27 (2024) |
Therapeutic Potential of Iron Chelators in Viral Diseases: A Systematic Review |
(Eng)
|
|
Lori M., Khandani A., Dehghannoudeh G., Ohadi M., Ansari M.
|
| 卷 31, 编号 27 (2024) |
Combining Mendelian Randomization Analysis and 3D-QSAR to Investigate the Effectiveness of a New Series of Hydroxyquinolines in Osteoarthritis |
(Eng)
|
|
Lian Z., Su K., Lu H., Qu C., Ma X.
|
| 卷 31, 编号 29 (2024) |
An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes |
(Eng)
|
|
Gasmi A., Nasreen A., Lenchyk L., Lysiuk R., Peana M., Shapovalova N., Piscopo S., Komisarenko M., Shanaida M., Smetanina K., Antonyak H., Fira L., Lykhatskyi P., Fira D., Bjørklund G.
|
| 卷 31, 编号 29 (2024) |
Therapeutical Approach to Arterial Hypertension - Current State of the Art |
(Eng)
|
|
Radosavljevic M., Vučević D., Samardić J., Radenkovic M., Radosavljević T.
|
| 卷 31, 编号 29 (2024) |
The Epigenetic Contribution to the Pathogenesis of Psoriasis: Recent Advances |
(Eng)
|
|
Aslani S., Mirarefin S., Zarredar H., Asadi M., Javan M., Khosrojerdi A., Johnston T., Sahebkar A.
|
| 卷 31, 编号 29 (2024) |
Role of Circular RNAs in Prostate Cancer |
(Eng)
|
|
Chen F., Zhang F., Liu Y., Leng Y.
|
| 卷 31, 编号 27 (2024) |
How Important is the Metal-free Catalytic Knoevenagel Reaction in Medicinal Chemistry? An Updated Review |
(Eng)
|
|
Johari S., Johan M., Khaligh N.
|
| 卷 31, 编号 27 (2024) |
Small Molecule Inhibitors against the Bacterial Pathogen Brucella |
(Eng)
|
|
Wu Y., Guo Y., Ma Y., Yu H., Wang Z.
|
| 卷 31, 编号 27 (2024) |
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review |
(Eng)
|
|
Cabeza M.
|
| 卷 31, 编号 26 (2024) |
Current Development of Data Resources and Bioinformatics Tools for Anticoronavirus Peptide |
(Eng)
|
|
Li B., Li M., Lu C., Wu Y., Chen H., He B.
|
| 卷 31, 编号 26 (2024) |
In Silico Immunogenicity Assessment of Therapeutic Peptides |
(Eng)
|
|
Li W., Wei J., Jiang Q., Zhou Y., Yan X., Xiang C., Huang J.
|
| 卷 31, 编号 26 (2024) |
Recent Advances in Protein Folding Pathway Prediction through Computational Methods |
(Eng)
|
|
Zhao K., Liang F., Xia Y., Hou M., Zhang G.
|
| 卷 31, 编号 26 (2024) |
A Structure-based Data Set of Protein-peptide Affinities and its Nonredundant Benchmark: Potential Applications in Computational Peptidology |
(Eng)
|
|
Wang S., Ye H., Shang S., Li Z., Peng Y., Zhou P.
|
| 卷 31, 编号 26 (2024) |
Natural Phenolic Compounds with Antithrombotic and Antiplatelet Effects: A Drug-likeness Approach |
(Eng)
|
|
Fernandes D., Gomes A., da Silva C., de Medeiros Henriques I., de Menezes R., Scotti M., Teles Y., Edrada-Ebel R., de Fatima Vanderlei de Souza M.
|
| 卷 31, 编号 26 (2024) |
Bile Acid-conjugate as a Promising Anticancer Agent: Recent Progress |
(Eng)
|
|
Rathod N., Mishra S.
|
| 卷 31, 编号 26 (2024) |
Application of Quercetin and its Novel Formulations in the Treatment of Malignancies of Central Nervous System: An Updated Review of Current Evidence based on Molecular Mechanisms |
(Eng)
|
|
Jamshidi-Mouselou M., Hashemi A., Jamshidi-Mouselou M., Farkhondeh T., Pourhanifeh M., Samarghandian S.
|
| 卷 31, 编号 26 (2024) |
Severity of COVID-19 in Pregnant Women: A Review on the Potential Role of Regulatory T Cells |
(Eng)
|
|
Saghafi N., Mahmoudi M., Momtazi-Borojeni A., Mirzaeian S., Tavasolian F., Sathyapalan T., Abdollahi E., Sahebkar A.
|
| 卷 31, 编号 26 (2024) |
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs |
(Eng)
|
|
Li X., Liu H., Wang F., Yuan J., Guan W., Xu G.
|
| 卷 31, 编号 27 (2024) |
Iron-related Biomarkers in the Diagnosis and Management of Iron Disorders |
(Eng)
|
|
Semenova Y., Bjørklund G., Butnariu M., Peana M.
|
| 卷 31, 编号 29 (2024) |
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment |
(Eng)
|
|
Ma C., Cui S., Xu R.
|
| 卷 31, 编号 29 (2024) |
Long Non-coding RNA DNM3OS: Pathogenic Roles and Molecular Mechanisms in Pathophysiological Processes |
(Eng)
|
|
Wang S., Hu Y., Wang R., Zhang Y., Yuan Q., Yuan C.
|
| 卷 31, 编号 30 (2024) |
A Review on the use of Synthetic and Recombinant Antigens for the Immunodiagnosis of Tegumentary Leishmaniasis |
(Eng)
|
|
Silva K., Ribeiro A., Gandra I., Resende C., da Silva Lopes L., Couto C., de Araujo Freire V., Barcelos I., Pereira S., Xavier S., da Paz M., Giunchetti R., Chávez-Fumagalli M., Gonçalves A., Coelho E., Galdino A.
|
| 卷 31, 编号 30 (2024) |
SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus |
(Eng)
|
|
Lukic N., Macvanin M., Gluvic Z., Rizzo M., Radak D., Suri J., Isenovic E.
|
| 卷 31, 编号 30 (2024) |
Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks |
(Eng)
|
|
Hassan W., Al-kaabi M., Akram N., Kassim M., Pantazi A.
|
| 卷 31, 编号 30 (2024) |
A Review on the Anticancer Activity of Carbazole-based Tricyclic Compounds |
(Eng)
|
|
Zhang H., Zhang W., Zhu M., Awadasseid A.
|
| 卷 31, 编号 30 (2024) |
Recent Update on the Protective Potentials of Resveratrol against Cisplatin-induced Ototoxicity: A Systematic Review |
(Eng)
|
|
Alsaikhan F., Jasim S., Margiana R., Opulencia M., Yasin G., Hammid A., Nasretdinova M., Mahdi A., Farhood B., Abedi-Firouzjah R., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 30 (2024) |
Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer |
(Eng)
|
|
Wang X., Jing H.
|
| 卷 31, 编号 30 (2024) |
Discovery of Pyroptosis-inducing Drugs and Antineoplastic Activity based on the ROS/ER Stress/Pyroptosis Axis |
(Eng)
|
|
Gan X., Xie J., Dong Z., Wu Y., Zeng X., Yang Z., Liu B., Zhu M., Wang B., Li W., Wang L., Zhang H., Wu J., Hu Y.
|
| 卷 31, 编号 30 (2024) |
TRIM65 Suppresses oxLDL-induced Endothelial Inflammation by Interaction with VCAM-1 in Atherogenesis |
(Eng)
|
|
Ma X., Zhou Y., Zhou Z., Liu H., Zhou B., Deng N., Zhou K., Tian Z., Wu Z., Liu X., Fu M., Jiang Z.
|
| 卷 31, 编号 30 (2024) |
Comprehensive Analysis of Ligand-receptor Interactions in Colon Adenocarcinoma to Identify of Tumor Microenvironment Oxidative Stress and Prognosis Model |
(Eng)
|
|
Hu J., Zhu W., Wang W., Yue X., Zhao P., Kong D.
|
| 卷 31, 编号 32 (2024) |
Phytochemicals as Therapeutic Agents against Cancer |
(Eng)
|
|
Bharti A.
|
| 卷 31, 编号 30 (2024) |
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults |
(Eng)
|
|
De S.
|
| 卷 31, 编号 3 (2024) |
Therapeutic and Diagnostic Agents based on Bioactive Endogenous and Exogenous Coordination Compounds |
(Eng)
|
|
Kostova I.
|
| 卷 31, 编号 3 (2024) |
Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs |
(Eng)
|
|
Tantra T., Singh Y., Patekar R., Kulkarni S., Kumar P., Thareja S.
|
| 卷 31, 编号 29 (2024) |
Mycobacterial Targets for Thiourea Derivatives: Opportunities for Virtual Screening in Tuberculosis Drug Discovery |
(Eng)
|
|
de Melo Milani V., Silva M., Camargo P., de Lima Ferreira Bispo M.
|
| 卷 31, 编号 29 (2024) |
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and their Pharmacological Implication: A Medicinal Chemistry-oriented Perspective Outline |
(Eng)
|
|
Rana V., Ghosh S., Bhatt A., Bisht D., Joshi G., Purohit P.
|
| 卷 31, 编号 29 (2024) |
Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials |
(Eng)
|
|
Heydari B., Sahebnasagh A., Omrani M., Azimi S., Dehghani M., Salehi-Abargouei A., Farman F., Saghafi F.
|
| 卷 31, 编号 3 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Bertho G.
|
| 卷 31, 编号 3 (2024) |
Protein Folding and Molecular Basis of Memory: Molecular Vibrations and Quantum Entanglement as Basis of Consciousness |
(Eng)
|
|
Atta-ur-Rahman .
|
| 卷 31, 编号 3 (2024) |
First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation |
(Eng)
|
|
De S.
|
| 卷 31, 编号 3 (2024) |
Perspectives and Prospects on the Application of DNA Aptamer in SARS-CoV-2 |
(Eng)
|
|
Liu Y., Hu B., Li J., Pei X., Hu X.
|
| 卷 31, 编号 3 (2024) |
Type 2 Diabetes and HDL Dysfunction: A Key Contributor to Glycemic Control |
(Eng)
|
|
Rotllan N., Julve J., Escolà-Gil J.
|
| 卷 31, 编号 3 (2024) |
Effectiveness In Vivo and In Vitro of Polymeric Nanoparticles as a Drug Release System in the Treatment of Leishmaniasis |
(Eng)
|
|
de Carvalho Moreira L., de Sousa Silva A., de Araújo Medeiros K., Oshiro Júnior J., da Silva D., de Lima Damasceno B.
|
| 卷 31, 编号 3 (2024) |
Novel Synthesized Tyrosinase Inhibitors: A Systematic Patent Review (2012-Present) |
(Eng)
|
|
Beltran E., Serafini M., Alves I., Aragón Novoa D.
|
| 卷 31, 编号 32 (2024) |
Alkaloids as Additional Weapons in the Fight against Breast Cancer: A Review |
(Eng)
|
|
Chahat ., Jha K., Bhatia R., Chawla P.
|
| 卷 31, 编号 2 (2024) |
A Quinquennial Review of Potent LSD1 Inhibitors Explored for the Treatment of Different Cancers, with Special Focus on SAR Studies |
(Eng)
|
|
Sheikh K., Iqubal A., Alam M., Akhter M., Khan M., Ehtaishamul Haque S., Parvez S., Jahangir U., Amir M., Khanna S., Shaquiquzzaman M.
|
| 卷 31, 编号 21 (2024) |
SETD1A-mediated Methylation of H3K4me3 Inhibits Ferroptosis in Non-small Cell Lung Cancer by Regulating the WTAPP1/WTAP Axis |
(Eng)
|
|
Wang D., Zu Y., Sun W., Fan X.
|
| 卷 31, 编号 21 (2024) |
Efficacy of the Novel Formulation of Topical Liothyronine and Liothyronine-insulin in Mild to Moderate Diabetic Foot Ulcer: A Randomized, Triple-blind Clinical Trial |
(Eng)
|
|
Saghafi F., Khalilzadeh S., Ramezani V., Pasandeh F., Fallahzadeh H., Sahebnasagh A.
|
| 卷 31, 编号 22 (2024) |
Potential Drugs in COVID-19 Management |
(Eng)
|
|
Gasmi A., Noor S., Menzel A., Khanyk N., Semenova Y., Lysiuk R., Beley N., Bolibrukh L., Gasmi Benahmed A., Storchylo O., Bjørklund G.
|
| 卷 31, 编号 22 (2024) |
PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal |
(Eng)
|
|
Romo-Perez A., Domínguez-Gómez G., Chávez-Blanco A., González-Fierro A., Correa-Basurto J., Dueñas-González A.
|
| 卷 31, 编号 22 (2024) |
Multiple Protein Biomarkers and Different Treatment Strategies for Colorectal Carcinoma: A Comprehensive Prospective |
(Eng)
|
|
Chakraborty B., Agarwal S., Kori S., Das R., Kashaw V., Iyer A., Kashaw S.
|
| 卷 31, 编号 22 (2024) |
Performance of Green Desymmetrization Methods toward Bioactive Cephalostatin Analogues |
(Eng)
|
|
Nawasreh M., Tahtamouni L.
|
| 卷 31, 编号 22 (2024) |
Detection of Circulating Cell-free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-analysis |
(Eng)
|
|
Aalami A., Aalami F., Aliabadi E., Amirabadi A., Sahebkar A.
|
| 卷 31, 编号 22 (2024) |
Does Laterality in Breast Cancer still have the Importance to be Studied? A Meta-analysis of Patients with Breast Cancer |
(Eng)
|
|
Zheng X., Xu C., Ganesan K., Chen H., Cheung Y., Chen J.
|
| 卷 31, 编号 22 (2024) |
Synthesis of β-Amino Carbonyl 6-(Aminomethyl)- and 6-(Hydroxymethyl)pyrazolopyrimidines for DPP-4 Inhibition Study |
(Eng)
|
|
Chung C., Tseng C., Li S., Zeng W., Lin Y., Hu Y., Jiang W., Huang G., Tsai H., Wong F.
|
| 卷 31, 编号 22 (2024) |
TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells |
(Eng)
|
|
Liu G., Wang H., Ran R., Wang Y., Li Y.
|
| 卷 31, 编号 21 (2024) |
Association of PD-L1 Expression with Clinicopathologic Characters in Gastric Cancer: A Comprehensive Meta-analysis |
(Eng)
|
|
Han Z., Wang N., Qiao Q., He X., Wang N.
|
| 卷 31, 编号 21 (2024) |
New Molecules of Importance in the Prevention and Treatment of Acne: A Systematic Patent Review (2016-2020) |
(Eng)
|
|
Calderón-Pardo D., Serafini M., Alves I., Aragón D.
|
| 卷 31, 编号 21 (2024) |
Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2 |
(Eng)
|
|
Prabhakar P., Batiha G.
|
| 卷 31, 编号 2 (2024) |
Peptide-based PROTACs: Current Challenges and Future Perspectives |
(Eng)
|
|
Wang H., Chen M., Zhang X., Xie S., Qin J., Li J.
|
| 卷 31, 编号 2 (2024) |
Efficacy and Safety of Alirocumab and Evolocumab as Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis |
(Eng)
|
|
Ghasempour G., Zamani-Garmsiri F., Shaikhnia F., Soleimani A., Hosseini Fard S., Leila J., Teimuri S., Parvaz N., Mohammadi P., Najafi M.
|
| 卷 31, 编号 2 (2024) |
Resveratrol Inhibits Restenosis through Suppressing Proliferation, Migration and Trans-differentiation of Vascular Adventitia Fibroblasts via Activating SIRT1 |
(Eng)
|
|
Li M., Luo L., Xiong Y., Wang F., Xia Y., Zhang Z., Ke J.
|
| 卷 31, 编号 21 (2024) |
The Treatment of a New Entity in Advanced Non-small Cell Lung Cancer: MET Exon 14 Skipping Mutation |
(Eng)
|
|
Rocco D., Gravara L., Palazzolo G., Gridelli C.
|
| 卷 31, 编号 21 (2024) |
Advances in Drug Therapy for Gastrointestinal Stromal Tumour |
(Eng)
|
|
Liu J., Li J., Zhu Y., Jing R., Ding S., Zhang J., Zhao L., Chen Y., Shen J.
|
| 卷 31, 编号 21 (2024) |
Research Progress of Chitosan-based Multifunctional Nanoparticles in Cancer Targeted Therapy |
(Eng)
|
|
Lai C., Lin S., Liu W., Jin Y.
|
| 卷 31, 编号 21 (2024) |
Curcuminoids as Cell Signaling Pathway Modulators: A Potential Strategy for Cancer Prevention |
(Eng)
|
|
Noor A., Shafi S., Sehar N., Qadir I., Bilquees ., Rashid S., Arafah A., Rasool S., Dar N., Masoodi M., Rehman M.
|
| 卷 31, 编号 21 (2024) |
Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19 |
(Eng)
|
|
Gasmi A., Tippairote T., Mujawdiya P., Menzel A., Lysiuk R., Shanaida M., Lenchyk L., Peana M., Bjørklund G.
|
| 卷 31, 编号 21 (2024) |
Hydrogen Sulfide: Physiological Roles and Therapeutic Implications against COVID-19 |
(Eng)
|
|
Abolfazli S., Ebrahimi N., Morabi E., Asgari Yazdi M., Zengin G., Sathyapalan T., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 21 (2024) |
Therapeutic Effects of Statins: Promising Drug for Topical and Transdermal Administration |
(Eng)
|
|
Zahedipour F., Hosseini S., Reiner ., Tedeschi-Reiner E., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 22 (2024) |
miR-204-5p Plays a Critical Role in the Pathogenesis of Depression and Anti-depression Action of Venlafaxine in the Hippocampus of Mice |
(Eng)
|
|
Guan W., Wu X., Jin X., Sheng X., Fan Y.
|
| 卷 31, 编号 22 (2024) |
Pharmacokinetics of Anti-rheumatic Drugs Methotrexate and Tofacitinib with its Metabolite M9 in Rats by UPLC-MS/MS |
(Eng)
|
|
Gu E., Xue L., Zhou C., Xia Y., Dai G.
|
| 卷 31, 编号 25 (2024) |
Current Trends in the Development of Electrochemical Biosensor for Detecting Analytes from Sweat |
(Eng)
|
|
Singh A., Sharma A., Dubey A., Arya S.
|
| 卷 31, 编号 25 (2024) |
Biogenic Carbon Quantum Dots: Synthesis and Applications |
(Eng)
|
|
Deb A., Chowdhury D.
|
| 卷 31, 编号 25 (2024) |
Recent Updates on Interaction Studies and Drug Delivery of Antimalarials with Serum Albumin Proteins |
(Eng)
|
|
Azeem K., Irfan I., Rashid Q., Singh S., Patel R., Abid M.
|
| 卷 31, 编号 25 (2024) |
Therapeutic Potential of Decoys for Prostate Cancers: A Review of Recent Updates |
(Eng)
|
|
Rezaei S., Mahjoubin-Tehran M., Iratni R., Sahebkar A.
|
| 卷 31, 编号 25 (2024) |
Protective Effects of Curcumin and its Analogues via the Nrf2 Pathway in Metabolic Syndrome |
(Eng)
|
|
Rajabi S., Darroudi M., Naseri K., Farkhondeh T., Samarghandian S.
|
| 卷 31, 编号 25 (2024) |
Association of Cystatin C Level with All-cause Mortality in Patients with Liver Cirrhosis: A Meta-analysis |
(Eng)
|
|
Wang X., Xu W., Yao L., Jie Y., Gao Z., Fan Y.
|
| 卷 31, 编号 25 (2024) |
Expression of Circulating miR-21 and -29 and their Association with Myocardial Fibrosis in Hypertrophic Cardiomyopathy |
(Eng)
|
|
Tousoulis D., Tsioufis K., Vlachopoulos C., Angelopoulos A., Oikonomou E., Antonopoulos A., Theofilis P., Zisimos K., Katsarou O., Gazouli M., Lazaros G., Papanikolaou P., Siasos G.
|
| 卷 31, 编号 25 (2024) |
Synthesis and Biological Evaluations of Granulatamide B and its Structural Analogues |
(Eng)
|
|
Matulja D., Grbčić P., Matijević G., Babić S., Bojanić K., Laclef S., Vrček V., Čo-Rakovac R., Pavelić S., Marković D.
|
| 卷 31, 编号 25 (2024) |
Leukemia Inhibitory Factor Protects against Degeneration of Cone Photoreceptors Caused by RPE65 Deficiency |
(Eng)
|
|
Dong S., Zhen F., Zou T., Zhou Y., Wu J., Wang T., Zhang H.
|
| 卷 31, 编号 25 (2024) |
Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma |
(Eng)
|
|
Liu J., Li H., Zhang N., Dong Q., Liang Z.
|
| 卷 31, 编号 25 (2024) |
Carbon Nanocomposites-based Electrochemical Sensors and Biosensors for Biomedical Diagnostics |
(Eng)
|
|
Kannan P., Maduraiveeran G.
|
| 卷 31, 编号 25 (2024) |
Electrochemical Label-free Methods for Ultrasensitive Multiplex Protein Profiling of Infectious Diseases |
(Eng)
|
|
Madhurantakam S., Churcher N., Kumar R., Prasad S.
|
| 卷 31, 编号 24 (2024) |
Berberine Decreases Thrombosis Potential Induced by a High-choline Diet by Inhibiting CutC Enzyme |
(Eng)
|
|
Qu H., Zhang Y., Shi J., Zhao Y., Gao J., Gao Z., Shi D.
|
| 卷 31, 编号 22 (2024) |
High-expression of FABP4 in Tubules is a Risk Factor for Poor Prognosis in DKD Patients |
(Eng)
|
|
Huang Y., Cui X., Li Z., Yuan S., Han Y., Xu X., Fu X., Shi K., Zhang Z., Wei J., Xia S., Xiao Y., Xue S., Sun L., Liu H., Zhu X.
|
| 卷 31, 编号 24 (2024) |
Research Progress in Estrogen-related Receptor Gamma (ERRγ) Agonists and Inverse Agonists |
(Eng)
|
|
Zheng Y., Du Y., Zhang H., Lv H., Yan Z., Dong N., Li Q., Wang T.
|
| 卷 31, 编号 24 (2024) |
Curcumin and its Derivatives Targeting Multiple Signaling Pathways to Elicit Anticancer Activity: A Comprehensive Perspective |
(Eng)
|
|
Fatima F., Chourasiya N., Mishra M., Kori S., Pathak S., Das R., Kashaw V., Iyer A., Kashaw S.
|
| 卷 31, 编号 24 (2024) |
Anti-gout and Urate-lowering Potentials of Curcumin: A Review from Bench to Beside |
(Eng)
|
|
Jafari-Nozad A., Jafari A., Yousefi S., Bakhshi H., Farkhondeh T., Samarghandian S.
|
| 卷 31, 编号 24 (2024) |
Protective Roles and Therapeutic Effects of Gallic Acid in the Treatment of Cardiovascular Diseases: Current Trends and Future Directions |
(Eng)
|
|
Momeni Z., Danesh S., Ahmadpour M., Eshraghi R., Farkhondeh T., Pourhanifeh M., Samarghandian S.
|
| 卷 31, 编号 24 (2024) |
To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds |
(Eng)
|
|
Bhattacharjee B., Chakrovorty A., Biswas M., Samadder A., Nandi S.
|
| 卷 31, 编号 24 (2024) |
Meta-analysis of the Impact of Bariatric Surgery on Circulating TMAO Levels as a Predictor of Cardiovascular Disease Risk |
(Eng)
|
|
Jamialahmadi T., Simental-Mendia L., Zengin G., Almahmeed W., Kesharwani P., Sahebkar A.
|
| 卷 31, 编号 24 (2024) |
Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors |
(Eng)
|
|
Olgen S., Kaleli S., Karaca B., Demirel U., Bristow H.
|
| 卷 31, 编号 24 (2024) |
LINC00891 Promotes Tumorigenesis and Metastasis of Thyroid Cancer by Regulating SMAD2/3 via EZH2 |
(Eng)
|
|
Si Y., Wen J., Hu C., Chen H., Lin L., Xu Y., Ren D., Meng X., Wang Y., Xia E., Bhandari A., Wang O.
|
| 卷 31, 编号 24 (2024) |
Mass Spectrometry-based Detection of Mycotoxins in Imported Meat and their Perspective Role on Myocardial Apoptosis |
(Eng)
|
|
Ansari M., Al Abbasi F., Hosawi S., Baig M., Alhayyani S., Kumar V., Asar T., Anwar F.
|
| 卷 31, 编号 26 (2024) |
Computational Methods and Artificial Intelligence in the Discovery and Development of Therapeutic Peptides and Beyond |
(Eng)
|
|
Huang J.
|
| 301 - 400 的 400 信息 |
<< < 1 2 3 4
|
